Patents
Patents for C07C 243 - Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes (2,826)
03/2003
03/26/2003EP1196374B1 Process of preparing a high-energy softening agent
03/26/2003CN1406223A Protease inhibitor and their pharmaceutical uses
03/20/2003WO2002094768A3 Aza hydroxylated ethyl amine compounds
03/12/2003EP1289935A1 Excitatory amino acid receptor modulators
03/06/2003WO2003018557A1 Hydrazinopeptoids and their uses for treating cancers
03/06/2003US20030041936 Amidation an ester with amine; nitration; activated plasticizier
03/06/2003CA2430267A1 Hydrazinopeptoids and their uses for treating cancers
03/04/2003US6528655 Aromatic derivatives with HIV integrase inhibitory properties
02/2003
02/25/2003US6525020 For drug delivery
02/20/2003WO2003014296A2 A group of novel anti-cancer compounds with specific structure
02/20/2003CA2456144A1 A group of novel anti-cancer compounds with specific structure
02/19/2003CN1398249A Perfluoroisopropylbenzene derivatives
02/18/2003US6521431 Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
02/13/2003US20030032742 Free radical inhibitors for quenching aqueous phase polymer growth and related methods
01/2003
01/29/2003EP1279662A1 Process for preparing phenylcyclohexan-1-ylcarboxylic acids
01/29/2003EP1278719A1 Naphthamide neurokinin antagonists for use as medicaments
01/23/2003WO2003006003A1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
01/23/2003US20030018073 Photochemistry releasing
01/23/2003CA2451569A1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
01/21/2003US6509503 Process for preparing pesticidal intermediates
01/16/2003WO2002046129A3 Inhibitors of histone deacetylase
01/16/2003US20030010963 Organic electrochromic materials and polymers for optical attenuation in the near infrared region
01/14/2003US6506798 4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors
01/14/2003CA2222303C Use of at least one no synthase inhibitor for treating sensitive skin
01/09/2003US20030008900 Compounds and compositions for delivering active agents
01/08/2003EP1272476A1 2-phenyl-2h-pyridazine-3-ones
01/08/2003EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors
01/07/2003US6503949 Glucagon antagonists/inverse agonists
12/2002
12/27/2002WO2002056874A3 Lipid-based nitric oxide donors
12/26/2002US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
12/19/2002WO2002100410A1 Methods of treating alzheimer's disease
12/19/2002WO2002070541A3 Peptide deformylase inhibitors
12/19/2002WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use
12/19/2002WO2002042248A3 Naphthalene derivatives
12/19/2002CA2449948A1 Methods of treating alzheimer's disease
12/11/2002EP1264836A1 Processes for the preparation of indolopyrrolocarbazole derivatives
12/11/2002EP1264822A2 Stabiliser modification
12/11/2002EP1264819A1 Process for inhibiting polymerization of a vinyl compound
12/11/2002EP1263849A1 Degradable cross-linking agents and cross-linked network polymers formed therewith
12/11/2002EP1058678B1 Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes
12/11/2002EP0752813B1 Inhibitors of metazoan parasite proteases
12/10/2002US6492363 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
12/04/2002EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
11/2002
11/28/2002WO2002094768A2 Aza hydroxylated ethyl amine compounds
11/28/2002CA2448084A1 Aza hydroxylated ethyl amine compounds
11/21/2002US20020173469 Protease inhibitors
11/19/2002US6482947 Substituted (hetero) aryl compounds, process for their preparation, agents containing them and their use as safeners
11/07/2002WO2001047866A9 Substituted 1 and 2 naphthol mannich bases
11/07/2002US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
10/2002
10/31/2002WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002WO2002042412A3 Protease inhibitors and their pharmaceutical uses
10/30/2002EP1253128A1 Perfluoroisopropylbenzene derivatives
10/29/2002US6472538 High yield coupling, hydrogenation and cyclization to form chemical intermediates for herbicides
10/15/2002US6465694 Method for preparation of polyethylene glycol aldehyde derivatives
10/15/2002US6465693 Metal-catalyzed arylations of hydrazines, hydrazones, and related substrates
10/09/2002EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/03/2002US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
10/02/2002CN1372549A Fungicidies
09/2002
09/25/2002EP1243577A1 Novel phenylalanine derivatives
09/19/2002WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
09/17/2002US6451792 Matrix metalloprotease inhibitors
09/12/2002WO2002070541A2 Peptide deformylase inhibitors
09/12/2002WO2002070464A2 Hydrazones and their therapeutic use
09/12/2002US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
09/12/2002US20020127202 Compounds and compositions for delivering active agents
09/12/2002CA2439827A1 Peptide deformylase inhibitors
09/11/2002CN1090612C Amine derivatives of oxo-and hydroxy-substituted hydrocarbons
09/10/2002CA2042857C Curable bismaleide systems
09/06/2002WO2002026692A3 Method for producing dnda
09/04/2002CN1090174C Improved process for hydrocyanation of diolefins and isomerization of nonconjugated 2-alkyl-3-monoalkenenitriles
09/04/2002CN1090173C Concentration method of aqueous acrylamide solution
08/2002
08/29/2002WO2002002520A3 Compounds to treat alzheimer's disease
08/29/2002WO2002002506A3 Compounds to treat alzheimer's disease
08/29/2002US20020120149 Substituted hydrazine derivatives
08/29/2002US20020119910 Drug delivery
08/29/2002DE10107227A1 Verfahren zur Herstellung von 4-substituierten 2-Alkyl- und 2-Alkoxylbiphenylen A process for the preparation of 4-substituted 2-alkyl and 2-Alkoxylbiphenylen
08/28/2002EP1140956B1 Ligands and complexes for enantioselective hydrogenation
08/28/2002CN1089749C Pesticidal hydrazide derivatives
08/28/2002CN1089748C Method for synthesizing aryl hydrazine through reduction of diazo compound derivative
08/22/2002US20020115880 Process for preparing 4-substituted 2-alkylbiphenyls and 2-alkoxylbiphenyls
08/21/2002EP1233009A2 Method for production of 4-substituted 2-alkylbiphenyls and 2-alcoxybiphenyls
08/20/2002CA2237033C Improved process for hydrocyanation of diolefins and isomerization of nonconjugated 2-alkyl-3-monoalkenenitriles
08/14/2002DE10105014A1 Neues Verfahren zur Herstellung von Monoamiden der DTPA New process for the preparation of monoamides of the DTPA
08/08/2002WO2002002518A3 Compounds to treat alzheimer's disease
08/01/2002WO2002059080A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
08/01/2002WO2002059076A1 Method for producing dtpa monoamides
08/01/2002WO2002002505A3 Compounds to treat alzheimer's disease
08/01/2002US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone
08/01/2002CA2435829A1 Trisubstituted carbocyclic cyclophilin binding compounds and their use
07/2002
07/31/2002EP1226106A1 Process for the preparation of insecticidal pheynylhydrazine derivatives
07/25/2002WO2002056874A2 Lipid-based nitric oxide donors
07/25/2002US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases
07/25/2002CA2443080A1 Lipid-based nitric oxide donors
07/24/2002CN1360568A Diacylhydrazine derivs.
07/17/2002EP1039902A4 Inhibitors of gap junction communication
07/16/2002US6420600 Hydroxyalkylphenyldiamides
07/16/2002US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury
07/09/2002US6417178 Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
07/04/2002WO2002051905A1 Photobase generators, curable compositions prepared by using the same and process of curing
07/04/2002WO2002051824A1 Amidinophenylalanine derivatives as thrombin inhibitors
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 29